COVID-19 protective antibody therapy development through single cell proteogenomic sequencing

  • Faster candidate discovery
  • Broad target
  • Scalable

Our partners

"For our most vulnerable populations, there is an urgent need for protective antibody against coronavirus."

COVID-19 pandemic, caused by SARS-CoV-2 virus, is threatening lives globally


Immunocompromised individuals, such as those with cancer, are especially at risk


Antibody therapy is a proven method for immediate protections for the immunocompromised or the seriously ill

OUR MISSION

To protect the most vulnerable immunocompromised patients against coronavirus infections

The Technology

Fast

Fast

Accelerate antibody discovery process using single cell proteogenomics

Broad target

Broad Target

Comprehensive screening to select antibody with the broadest coverage

Scalable

Scalable

Able to include samples with different geographical and ethnical background

About Proteona Antibody Protection GmbH

Proteona Antibody Protection GmbH (PAP) is a biomedical company operating at the forefront of the fight against COVID-19 using single cell sequencing technology to discover neutralizing antibodies. Proteona’s vision is to accelerate treatment development for the most vulnerable, immunocompromised patients.

We do this by utilizing our own single cell technologies to identify the best candidate antibodies and then moving those antibodies through functional testing toward the clinic by tapping on the individual strengths of a team of the top international companies and research institutes in the world who have agreed to form an alliance for the purpose of fighting COVID-19.

Proteona Antibody Protection GmbH was established in 2020 in response to the dire need of immunocompromised individuals, such as those with blood cancer, for a targeted treatment against COVID-19. Its parent company, Proteona, is already active in Singapore and Germany, where it provides single-cell multi-omics data for researchers, clinicians and pharma companies for drug discovery and for treatment optimization for blood cancer patients.


Contact Information

Proteona Antibody Protection GmbH
Cologne, Germany

antibodyprotection@proteona.com

https://proteonaantibodyprotection.com/en/

Proteona Pte. Ltd.
Singapore, Singapore

info@proteona.com

https://proteona.com

Connect with us on LinkedIn
World map